Serum plant and other noncholesterol sterols, cholesterol metabolism and 22-year mortality among middle-aged men

Atherosclerosis

Volumn 210, Issue 1, 2010, Pages 282-287

  Strandberg, Timo E ^a   Gylling, Helena ^b   Tilvis, Reijo S ^c   Miettinen, Tatu A ^c  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Absorption; Cholestanol; Cholesterol; Elderly; Plant sterols; Synthesis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; ASPARTATE AMINOTRANSFERASE; CAMPESTEROL; CHOLESTANOL; DESMOSTEROL; GAMMA GLUTAMYLTRANSFERASE; LATHOSTEROL; SITOSTEROL;

ABSORPTION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EXERCISE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SOCIAL STATUS; SOCIOECONOMICS; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

CARDIOVASCULAR DISEASES; CHOLESTEROL; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MORTALITY; PHYTOSTEROLS; PROSPECTIVE STUDIES; STEROLS;

EID: 77952429165     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.11.007     Document Type: Article

References (30)

1. Weihrauch J.L., Gardner J.M. Sterol contents of foods of plant origin. J Am Diet Assoc 1978, 73:39-47.
2. Patel M.D., Thompson P.D. Phytosterols and vascular disease. Atherosclerosis 2006, 186:12-19.
3. John S., Sorokin A.V., Thompson P.D. Phytosterols and vascular disease. Curr Opin Lipidol 2007, 18:35-40.
4. Katan M.B., Grundy S.M., Jones P., et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003, 78:965-978.
5. Sudhop T., Gottwald B.M., von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism 2002, 51:1519-1521.
6. van Himbergen T.M., Matthan N.R., Resteghini N.A., et al. Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers. J Lipid Res 2009, 50:730-739.
7. Miettinen T.A., Gylling H. The effects of statins and sitosterols: benefit or not?. Curr Atheroscler Rep 2009, 11:23-27.
8. Miettinen T.A., Tilvis R.S., Kesaniemi Y.A. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990, 131:20-31.
9. Matthan N.R., Lichtenstein A.H. Approaches to measuring cholesterol absorption in humans. Atherosclerosis 2004, 174:197-205.
10. Pinedo S., Vissers M.N., von Bergmann K., et al. Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk Population Study. J Lipid Res 2007, 48:139-144.
11. Escurriol V., Cofan M., Moreno-Iribas C., Larranaga N., Martinez C., Navarro C., Rodriguez L., Gonzalez C.A., Corella D., Ros E. Phytosterol plasma concentrations and coronary heart disease in the prospective Spanish EPIC cohort. J Lipid Res 2009, (September (28)).
12. Silbernagel G., Fauler G., Renner W., Landl E.M., Hoffmann M.M., Winkelmann B.R., Boehm B.O., Märtz W. The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease. J Lipid Res 2009, 50:334-341.
13. Matthan N.R., Pencina M., LaRocque J.M., et al. Alterations in cholesterol absorption/synthesis markers characterize Framingham Offspring Study participants with CHD. J Lipid Res 2009, 50:1927-1935.
14. Weingärtner O., Weingärtner N., Scheller B., et al. Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis. Coron Artery Dis 2009, 20:376-382.
15. Weingärtner O., Lutjohann D., Rogacev K.S., et al. Endogenous cholesterol synthesis, but not cholesterol absorption is associated with early atherosclerosis. Eur Heart J 2009, 30:766. (Abstract Supplement).
16. Strandberg T.E., Salomaa V.V., Vanhanen H., Miettinen T.A. Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men. Diabetes 1996, 45:755-761.
17. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, an Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, an Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report. Circulation 2002, 106:3143-3421.
18. Filippatos T.D., Mikhailidis D.P. Ezetimibe lipid-lowering drugs acting at the level of the gastrointestinal tract. Curr Pharm Des 2009, 15(5):490-516.
19. Assmann G., Kannenberg F., Ramey D.R., Musliner T.A., Gutkin S.W., Veltri E.P. Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia. Curr Med Res Opin 2008, 24:249-259.
20. Assmann G., Cullen P., Erbey J., Ramey D.R., Kannenberg F., Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events inmen: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study. Nutr Metab Cardiovasc Dis 2006, 16:13-21.
21. Miettinen T.A., Gylling H., Strandberg T., Sarna S. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators. BMJ 1998, 316:1127-1130.
22. Wilund K.R., Feeney L.A., Tomayko E.J., Weiss E.P., Hagberg J.H. Effects of endurance exercise training on markers of cholesterol absorption and synthesis. Physiol Res 2008, (July (25)).
23. Simonen P.P., Gylling H., Howard A.N., Miettinen T.A. Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am J Clin Nutr 2000, 72:82-88.
24. Simonen P.P., Gylling H., Miettinen T.A. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care 2002, 25:1511-1515.
25. Simonen P.P., Gylling H., Miettinen T.A. Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics. Obes Res 2002, 10:328-335.
26. Pihlajamäki J., Gylling H., Miettinen T.A., Laakso M. Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 2004, 45:507-512.
27. Strandberg T.E., Pitkala K., Tilvis R.S., Miettinen T.A. J Am Coll Cardiol 2006, 48:708-714.
28. Morley J.E., Haren M.T., Rolland Y., Kim M.J., Frailty Med Clin North Am 2006, 90:837-847.
29. Strandberg T.E., Pitkala K.H. Frailty in elderly people. Lancet 2007, 369:1328-1329.
30. Kalantar-Zadeh K., Horwich T.B., Oreopoulos A., et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 2007, 10:433-442.